ClinicalTrials.Veeva

Menu

Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis

E

Elvan Onur Kirimker

Status

Completed

Conditions

Liver Transplant; Complications
Portal Vein Thrombosis

Treatments

Procedure: living donor liver transplantation
Procedure: Thrombectomy or interposition graft

Study type

Observational

Funder types

Other

Identifiers

NCT05132192
PVT-LDLT-ANK

Details and patient eligibility

About

Data of demographic, clinical, laboratory and imaging studies of living donor liver transplantation (LDLT) recipients from two transplant centers were collected. Survival and morbidity rates between patients with and without portal vein thrombosis (PVT) were compared. Risk factors of mortality in the setting of PVT were identified. Intraoperative portal flow measurements were compared before and after portal flow restoration.

Full description

LDLTs performed in two experienced centers (Ankara University Ibn-i Sina Hospital and Ankara Güven Hospital) between January 2013 and February 2020 were evaluated and included in the cohort study. Deceased donor liver transplants and pediatric transplants (deceased or living) were excluded from the study.

Data relating to this study including patient history, preoperative laboratory and imaging test results, reports of surgical procedures or interventions, intraoperative anesthesia records, post-operative laboratory trends, and postoperative complications were extracted from the computer-based data management system and prospectively maintained in transplant databases in both centers. Recipients of LDLT were divided in two groups according to the presence or absence of PVT.

Portal flow measurements were recorded with VeriQ (Medistim ASA, Oslo, Norway) Doppler flowmeter device in one of the centers later in the study period.

The follow-up and recordings of the patients were maintained in the outpatient clinics of the two centers.

The most serious complication experienced by each patient was recorded according to the Clavien-Dindo classification Primary outcome of the current study was the survival rates of patients with and without PVT Secondary outcomes of the study included morbidity in patients with and without PVT after LDLT, risk factors of mortality after LDLT to patients with PVT and comparison of intraoperative portal flow measurements between patients with and without PVT

Enrollment

335 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients underwent liver transplantation

Exclusion criteria

  • Pediatric liver transplants
  • Deceased donor liver transplants

Trial design

335 participants in 2 patient groups

PVT
Description:
Patients with pretransplant portal vein thrombosis
Treatment:
Procedure: living donor liver transplantation
Procedure: Thrombectomy or interposition graft
non-PVT
Description:
Patients without pretransplant portal vein thrombosis
Treatment:
Procedure: living donor liver transplantation

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems